Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Abeloff

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancersG Goodwin, J H Shaper, M D Abeloff, et al.
Journal of the National Cancer Institute|June 1, 1978
Response of plasma histaminase activity to heparin in normal subjects and in patients with small cell carcinoma of the lungD S Ettinger, S B Baylin, D Minaberry, et al.
Cancer Research|April 1, 1986
Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithineG D Luk, M D Abeloff, P P McCann, et al.
The New England Journal of Medicine|June 14, 1990
Decreased erythropoietin response in patients with the anemia of cancerC B Miller, R J Jones, S Piantadosi, et al.
Cancer Research|June 1, 1980
Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell cultureS B Baylin, M D Abeloff, G Goodwin, et al.
Cancer Treatment Reports|March 1, 1978
Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lungD S Ettinger, J E Karp, M D Abeloff, et al.
Surgery, Gynecology & Obstetrics|January 1, 1981
The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breastJ F Paone, M D Abeloff, D S Ettinger, et al.
Journal of the National Cancer Institute|November 1, 1980
Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseasesH D Todd, M S Coffee, T P Waalkes, et al.
Medical and Pediatric Oncology|January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breastW P Vaughan, P M Wilcox, P O Alderson, et al.
Journal of Surgical Oncology|June 1, 1982
Biological markers as an aid in the clinical management of patients with liver metastasesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancersG Goodwin, J H Shaper, M D Abeloff, et al.
Journal of the National Cancer Institute|June 1, 1978
Response of plasma histaminase activity to heparin in normal subjects and in patients with small cell carcinoma of the lungD S Ettinger, S B Baylin, D Minaberry, et al.
Cancer Research|April 1, 1986
Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithineG D Luk, M D Abeloff, P P McCann, et al.
The New England Journal of Medicine|June 14, 1990
Decreased erythropoietin response in patients with the anemia of cancerC B Miller, R J Jones, S Piantadosi, et al.
Cancer Research|June 1, 1980
Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell cultureS B Baylin, M D Abeloff, G Goodwin, et al.
Cancer Treatment Reports|March 1, 1978
Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lungD S Ettinger, J E Karp, M D Abeloff, et al.
Surgery, Gynecology & Obstetrics|January 1, 1981
The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breastJ F Paone, M D Abeloff, D S Ettinger, et al.
Journal of the National Cancer Institute|November 1, 1980
Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseasesH D Todd, M S Coffee, T P Waalkes, et al.
Medical and Pediatric Oncology|January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breastW P Vaughan, P M Wilcox, P O Alderson, et al.
Journal of Surgical Oncology|June 1, 1982
Biological markers as an aid in the clinical management of patients with liver metastasesT P Waalkes, M D Abeloff, D S Ettinger, et al.
Pageof 9